Related references
Note: Only part of the references are listed.Class II Alloantibody and Mortality in Simultaneous Liver-Kidney Transplantation
J. G. O'Leary et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
De Novo Donor-Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients
H. Kaneku et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Impact of donor-specific antibodies on results of liver transplantation
Jacqueline G. O'Leary et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2013)
Tissue biopsy monitoring of operational tolerance in liver allograft recipients
Anthony J. Demetris et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2013)
Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation
Scott W. Biggins et al.
JOURNAL OF HEPATOLOGY (2013)
Liver transplantation with a strongly positive crossmatch: Case study and literature review
Garrett R. Leonard et al.
LIVER TRANSPLANTATION (2013)
Preformed class II donor-specific antibodies are associated with an increased risk of early rejection after liver transplantation
Jacqueline G. O'Leary et al.
LIVER TRANSPLANTATION (2013)
A Novel Pathway of Chronic Allograft Rejection Mediated by NK Cells and Alloantibody
T. Hirohashi et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Prevalence, Course and Impact of HLA Donor-Specific Antibodies in Liver Transplantation in the First Year
T. Taner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Mechanisms of action and effects of antibodies on the cells of the allograft
Elaine F. Reed
HUMAN IMMUNOLOGY (2012)
Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: Diagnostic considerations in the evaluation of liver allografts
Tomasz Kozlowski et al.
LIVER TRANSPLANTATION (2012)
Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with Chronic rejection and graft loss after liver transplantation
Hugo Kaneku et al.
LIVER TRANSPLANTATION (2012)
Risk of advanced fibrosis with grafts from hepatitis C antibody-positive donors: A multicenter cohort study
Jennifer C. Lai et al.
LIVER TRANSPLANTATION (2012)
Progressive graft fibrosis and donor-specific human leukocyte antigen antibodies in pediatric late liver allografts
Aya Miyagawa-Hayashino et al.
LIVER TRANSPLANTATION (2012)
Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection
Norah A. Terrault et al.
LIVER TRANSPLANTATION (2012)
Humoral immunity is involved in the development of pericentral fibrosis after pediatric live donor liver transplantation
Hiroyuki Yamada et al.
PEDIATRIC TRANSPLANTATION (2012)
High Mean Fluorescence Intensity Donor-Specific Anti-HLA Antibodies Associated With Chronic Rejection Postliver Transplant
J. G. O'Leary et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The Significance of Donor-Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation
A. I. Musat et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Interleukin-28B Polymorphisms Are Associated With Histological Recurrence and Treatment Response Following Liver Transplantation in Patients With Hepatitis C Virus Infection
Michael R. Charlton et al.
HEPATOLOGY (2011)
Liver Allograft Antibody-Mediated Rejection With Demonstration of Sinusoidal C4d Staining and Circulating Donor-Specific Antibodies
Tomasz Kozlowski et al.
LIVER TRANSPLANTATION (2011)
Human Liver Transplantation as a Model to Study Hepatitis C Virus Pathogenesis
Michael G. Hughes et al.
LIVER TRANSPLANTATION (2009)
Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin
Marina Berenguer
JOURNAL OF HEPATOLOGY (2008)
Liver transplantation for HCV cirrhosis:: Improved survival in recent years and increased severity of recurrent disease in female recipients:: Results of a long term retrospective study
Luca S. Belli et al.
LIVER TRANSPLANTATION (2007)
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation:: A randomized controlled study
Jose A. Carrion et al.
GASTROENTEROLOGY (2007)
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: A review and quantitative analysis
C. S. Wang et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Factors differentially correlated with the outcome of liver transplantation in HCV+ and HCV- recipients
E Velidedeoglu et al.
TRANSPLANTATION (2004)
A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation
NN Onaca et al.
LIVER TRANSPLANTATION (2003)
Liver transplant recipients older than 60 years have lower survival and higher incidence of malignancy
JI Herrero et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Report of the first international liver transplantation society expert panel consensus conference on liver transplantation and hepatitis C
RH Wiesner et al.
LIVER TRANSPLANTATION (2003)
The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients
E Gane
LIVER TRANSPLANTATION (2003)
The association between hepatitis C infection and survival after orthotopic liver transplantation
LM Forman et al.
GASTROENTEROLOGY (2002)
Effect of race on outcome of orthotopic liver transplantation: a cohort study
S Nair et al.
LANCET (2002)
Share Paper
